Méhtestrák: vizsgálatok itt: Svédország
8 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
- Where
- Lund, Solna, Uppsala
- Életkor
- 18 év and over
- People
- 480 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT06340568 · EU 2023-507525-42-00 - 3. fázisTaking peopleA Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
- Where
- Lund, Uppsala
- Életkor
- 18 év and over
- People
- 1123 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06952504 · EU 2024-519331-42-00 - 3. fázisTaking peopleDESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Where
- Linkoping, Lund, Solna, Uppsala
- Életkor
- 18 év and over
- People
- 600 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06989112 · EU 2023-508056-19-00 - 1/2. fázisTaking peopleStudy of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
- Where
- Lund, Stockholm
- Életkor
- 18 év to 130 év
- People
- 695 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05417594 · EU 2023-504984-17-00 - 1/2. fázisTaking peopleA Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
- Where
- Lund, Stockholm, Uppsala
- Életkor
- 18 év and over
- People
- 47 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07213609 - No phaseTaking peopleDay Care in Robotic Surgery Hysterectomy. Investigate Quality of Life and Safety With Same Day Discharge After Robotic Hysterectomy for Patients With Benign and Malignant Disease. A Multicenter Randomized Study With 3 Hospitals in Stockholm Sweden.
- Where
- Stockholm
- Életkor
- 18 év to 75 év
- People
- 300
- Run by
- Karolinska Institutet
See details and how to joinNCT07233811 - No phaseTaking peoplePrognostic and Diagnostic Added Value of Medical Imaging in Gynecological Cancer (PRODIGYN)
- Where
- Umeå
- Életkor
- 18 év and over
- People
- 120
- Run by
- Region Västerbotten
See details and how to joinNCT05855941 - 2/3. fázisTaking peopleStudy of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
- Where
- Linköping, Stockholm
- Életkor
- 18 év and over
- People
- 268 worldwide
- Run by
- Kartos Therapeutics, Inc.
See details and how to joinNCT05797831